Comparison of hyaluronic acid-based micelles and polyethylene glycol-based micelles on reversal of multidrug resistance and enhanced anticancer efficacy in vitro and in vivo

References

• Almalik A, Karimi S, Ouasti S, et al. (2013). Hyaluronic acid (HA) presentation as a tool to modulate and control the receptor-mediated uptake of HA-coated nanoparticles. Biomaterials 34:5369–80.
   PubMed Web of Science ®Google Scholar
• Bareford LM, Swaan PW. (2007). Endocytic mechanisms for targeted drug delivery. Adv Drug Deliv Rev 59:748–58.
   PubMed Web of Science ®Google Scholar
• Choi BH, Kim CG, Lim Y, et al. (2008). Curcumin down-regulates the multidrug-resistance mdr1b gene by inhibiting the PI3K/Akt/NF kappa B pathway. Cancer Lett 259:111–8.
   PubMed Web of Science ®Google Scholar
• Choi KY, Min KH, Yoon HY, et al. (2011). PEGylation of hyaluronic acid nanoparticles improves tumor targetability in vivo. Biomaterials 32:1880–9.
   PubMed Web of Science ®Google Scholar
• Choudhury H, Gorain B, Pandey M, et al. (2017). Recent advances in TPGS-based nanoparticles of docetaxel for improved chemotherapy. Int J Pharm 529:506–22.
   PubMed Web of Science ®Google Scholar
• Datir SR, Das M, Singh RP, Jain S. (2012). Hyaluronate tethered, “smart” multiwalled carbon nanotubes for tumor-targeted delivery of doxorubicin. Bioconjugate Chem 23:2201–13.
   PubMed Web of Science ®Google Scholar
• Duan J, Mansour HM, Zhang Y, et al. (2012). Reversion of multidrug resistance by co-encapsulation of doxorubicin and curcumin in chitosan/poly(butyl cyanoacrylate) nanoparticles. Int J Pharm 426:193–201.
   PubMed Web of Science ®Google Scholar
• Gao Y, Sarfraz MK, Clas S-D, et al. (2015). Hyaluronic acid-tocopherol succinate-based self-assembling micelles for targeted delivery of rifampicin to alveolar macrophages. J Biomed Nanotechnol 11:1312–29.
   PubMed Web of Science ®Google Scholar
• Han X, Li Z, Sun J, et al. (2015). Stealth CD44-targeted hyaluronic acid supramolecular nanoassemblies for doxorubicin delivery: probing the effect of uncovalent pegylation degree on cellular uptake and blood long circulation. J Control Release 197:29–40.
   PubMed Web of Science ®Google Scholar
• He B, Lin P, Jia Z, et al. (2013). The transport mechanisms of polymer nanoparticles in Caco-2 epithelial cells. Biomaterials 34:6082–98.
   PubMed Web of Science ®Google Scholar
• Jin X, Li M, Yin L, et al. (2017a). Tyroservatide-TPGS-paclitaxel liposomes: tyroservatide as a targeting ligand for improving breast cancer treatment. Nanomedicine 13:1105–15.
   PubMed Web of Science ®Google Scholar
• Jin X, Yang Q, Zhang Y. (2017b). Synergistic apoptotic effects of apigenin TPGS liposomes and tyroservatide: implications for effective treatment of lung cancer. Int J Nanomedicine 12:5109–18.
   PubMed Web of Science ®Google Scholar
• Kamal A, Reddy DR. Rajendar (2006). Polyethylene glycol (PEG) as an efficient recyclable medium for the synthesis of β-amino sulfides. Tetrahedron Lett 47:2261–4.
   Web of Science ®Google Scholar
• Karlsson PC, Hughes R, Rafter JJ, Bruce WR. (2005). Polyethylene glycol reduces inflammation and aberrant crypt foci in carcinogen-initiated rats. Cancer Lett 223:203–9.
   PubMed Web of Science ®Google Scholar
• Kedar U, Phutane P, Shidhaye S, Kadam V. (2010). Advances in polymeric micelles for drug delivery and tumor targeting. Nanomedicine 6:714–29.
   PubMed Web of Science ®Google Scholar
• Kim E, Yang J, Kim HO, et al. (2013). Hyaluronic acid receptor-targetable imidazolized nanovectors for induction of gastric cancer cell death by RNA interference. Biomaterials 34:4327–38.
   PubMed Web of Science ®Google Scholar
• Kumar V, Sharma VK, Kalonia DS. (2009). Effect of polyols on polyethylene glycol (PEG)-induced precipitation of proteins: impact on solubility, stability and conformation. Int J Pharm 366:38–43.
   PubMed Web of Science ®Google Scholar
• Li J, Ke W, Li H, et al. (2015). Endogenous stimuli-sensitive multistage polymeric micelleplex anticancer drug delivery system for efficient tumor penetration and cellular internalization. Adv Healthcare Mater 4:2206–19.
   Web of Science ®Google Scholar
• Ling G, Zhang P, Zhang W, et al. (2010). Development of novel self-assembled DS-PLGA hybrid nanoparticles for improving oral bioavailability of vincristine sulfate by P-gp inhibition. J Control Release 148:241–8.
   PubMed Web of Science ®Google Scholar
• Ma W, Guo Q, Li Y, et al. (2017). Co-assembly of doxorubicin and curcumin targeted micelles for synergistic delivery and improving anti-tumor efficacy. Eur J Pharm Biopharm 112:209–23.
   PubMed Web of Science ®Google Scholar
• Pommier Y, Leo E, Zhang H, Marchand C. (2010). DNA topoisomerases and their poisoning by anticancer and antibacterial drugs. Chem Biol 17:421–33.
   PubMed Web of Science ®Google Scholar
• Qian H, Yang Y, Wang X. (2011). Curcumin enhanced adriamycin-induced human liver-derived Hepatoma G2 cell death through activation of mitochondria-mediated apoptosis and autophagy. Eur J Pharm Sci 43:125–31.
   PubMed Web of Science ®Google Scholar
• Sahay G, Alakhova DY, Kabanov AV. (2010). Endocytosis of nanomedicines. J Control Release 145:182–95.
   PubMed Web of Science ®Google Scholar
• Tacar O, Sriamornsak P, Dass CR. (2013). Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems. J Pharm Pharmacol 65:157–70.
   PubMed Web of Science ®Google Scholar
• Wang BL, Shen YM, Zhang QW, et al. (2013). Codelivery of curcumin and doxorubicin by MPEG-PCL results in improved efficacy of systemically administered chemotherapy in mice with lung cancer. Int J Nanomed 8:3521–31.
   PubMedGoogle Scholar
• Wang J, Ma W, Guo Q, et al. (2016). The effect of dual-functional hyaluronic acid-vitamin E succinate micelles on targeting delivery of doxorubicin. Int J Nanomed 11:5851–70.,
   PubMed Web of Science ®Google Scholar
• Wang J, Ma W, Tu P. (2015). Synergistically improved anti-tumor efficacy by co-delivery doxorubicin and curcumin polymeric micelles. Macromol Biosci 15:1252–61.
   PubMed Web of Science ®Google Scholar
• Wang J, Sun J, Chen Q, et al. (2012). Star-shape copolymer of lysine-linked di-tocopherol polyethylene glycol 2000 succinate for doxorubicin delivery with reversal of multidrug resistance. Biomaterials 33:6877–88.
   PubMed Web of Science ®Google Scholar
• Yadav AK, Mishra P, Mishra AK, et al. (2007). Development and characterization of hyaluronic acid-anchored PLGA nanoparticulate carriers of doxorubicin. Nanomedicine 3:246–57.
   PubMed Web of Science ®Google Scholar
• Yang C, Wu T, Qi Y, Zhang Z. (2018). Recent advances in the application of vitamin E TPGS for drug delivery. Theranostics 8:464–85.
   PubMed Web of Science ®Google Scholar
• Yin M, Tan S, Bao Y, Zhang Z. (2017). Enhanced tumor therapy via drug co-delivery and in situ vascular-promoting strategy. J Control Release 258:108–20.
   PubMed Web of Science ®Google Scholar
• Youk HJ, Lee E, Choi MK, et al. (2005). Enhanced anticancer efficacy of alpha-tocopheryl succinate by conjugation with polyethylene glycol. J Control Release 107:43–52.
   PubMed Web of Science ®Google Scholar